MBOT — Microbot Medical Inc
NASDAQ · Healthcare · Medical Instruments & Supplies
$1.48
+$0.01 (+0.68%)
Microbot Medical Inc (MBOT) is a medical instruments & supplies company listed on NASDAQ. It is led by Harel Gadot, based in 175 Derby Street, Hingham, MA, United States, 02043, with about 43 employees. Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
Net income was -$3.6M. MBOT currently screens at market cap $123.9M.
Use this MBOT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MBOT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MBOT SEC filings page. Lician reads the product cache first so this HTML stays unique to Microbot Medical Inc even when a live quote feed is slow.
About Microbot Medical Inc
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
MBOT Key Statistics
Market Cap
$123.88M
Volume
227,987
Previous Close
$1.48
Day Range
$1.47 – $1.51
P/B Ratio
1.70
EPS
-$0.73
Revenue
$0.00
Net Income
-$11.44M
Gross Profit
$0.00
Free Cash Flow
$0.00
Employees
43
MBOT Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$11.44M | -$10.74M | -$13.17M | -$11.31M |
| EPS (Diluted) | -$0.73 | -$1.05 | -$1.81 | $0.00 |
Total Assets
$6.03M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$3.11M
Operating Cash Flow
-$8.83M
Free Cash Flow
$0.00
Microbot Medical Inc Company Information
- Co-Founder, President, CEO & Chairman
- Harel Gadot
- Headquarters
- 175 Derby Street, Hingham, MA, United States, 02043
- Website
- microbotmedical.com
- Phone
- 781 875 3605
- IPO / Founded
- 1992-03-25
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies